IJOHNS  Vol.4 No.3 , May 2015
Final Diagnosis of Pediatric Patients with Prolonged in Activated Partial Thromboplastin Time Preoperative Study
Introduction: Activated partial thromboplastin time (aPTT) is one of the most used coagulation tests in preoperative evaluation. Incidental detection of a prolonged aPTT is a problem in primary care, in which the general pediatrician should be able to attend its initial management. Objective: To describe final diagnosis of patients with prolonged aPTT in preoperative study. Materials and Methods: This is a descriptive study of patients referred from otorhinolaryngology. Results: Totally, 508 adenoidectomies and/or tonsillectomies were performed in our center, 38 of which referred patients (7.5%) with prolonged aPTT, and 30 of which met inclusion criteria. The median age was 4 years. 56.6% of patients were males. 76.6% of patients normalized aPTT at the second follow-up. Among these, 73.9% showed a normal study, 4.3% ha2d lupus anticoagulant and in 21.7% Von Willebrand disease was detected. Among patients that persisted with prolonged aPTT, 42.8% had coagulant factors deficiency, 28.5% had lupus anticoagulant and in 28.5% of patients a diagnosis could not be achieved with the tests used in the present study. Multivariate analysis did not show correlation between final diagnosis and the variables measured. Conclusion: The presence of a prolonged aPTT in children under preoperative study is due to a pre-analytic factor in the majority of cases or to the presence of lupus anticoagulant, normalizing values on follow-up. We suggest that a new aPTT be performed on these patients, and only those that persist altered or present a symptoms and family history of coagulation disorders be referred to hematology.

Cite this paper
Aguirre, N. , Córdova, F. , Jaime, F. , Fonseca, X. and Zúñiga, P. (2015) Final Diagnosis of Pediatric Patients with Prolonged in Activated Partial Thromboplastin Time Preoperative Study. International Journal of Otolaryngology and Head & Neck Surgery, 4, 241-247. doi: 10.4236/ijohns.2015.43041.
[1]   Anjali, A. and Steven, W. (2008) Bleeding Disorders. Pediatrics in Review, 29, 121-130.

[2]   Shah, M., O’Riordan, M. and Alexander, S. (2006) Evaluation of Prolonged aPTT Values in the Pediatric Population. Clinical Pediatrics, 45, 347-353.

[3]   Edlinger, G., Gallistl, S. and Muntean, W. (1996) Lupus Anticoagulant and Factor XII Activity in Children with Prolonged PTT. Thrombosis Research, 83, 403-404.

[4]   Katrin, F., Karl, L. and Philipp, V. (2005) Antiphospholipid Antibodies in Pediatric Patients with Prolonged Activated Partial Thromboplastin Time during Infection. Immunobiology, 210, 799-805.

[5]   Shiomou, K., Galanakis, E., Tzoufi, M., Tsaousi, C. and Papadopoulou, Z.L. (2002) Transient Lupus Anticoagulant and Prolonged Activated Partial Thromboplastin Time Secondary to Epstein-Barr Virus Infection. Scandinavian Journal of Infectious Diseases, 34, 67-69.

[6]   Mizumoto, H., Maihara, T., Hiejima, E., Shiota, M., Hata, A., Seto, S., Atsumi, T., Koike, T. and Hata, D. (2006) Transient Antiphospholipid Antibodies Associated with Acute Infections in Children: A Report of Three Cases and a Review of the Literature. European Journal of Pediatrics, 165, 484-488.

[7]   Blank, M., Krause, I., Fridkin, M., Keller, N., Kopolovic, J., Goldberg, I., Tobar, N. and Shoenfeld, Y. (2002) Bacterial Induction of Autoantibodies to Be-ta2-Glycoprotein-I Accounts for the Infectious Etiology of Antiphospholipid Syndrome. The Journal of Clinical Investigation, 109, 797-804.

[8]   Bermejo, A., Gonzalez, H., Abad, A., Figueroa, L., Munoz, R., Marcos, M., Cebeira, M.J. and Alvarez, F.J. (2013) Anticoagulante lúpico en pediatria. Experiencia en nuestro centro. Boletín de la sociedad de pediatría de asturias, cantabria, castilla y león, 53, 146-151.

[9]   Lippi, G., Salvagno, G.L., Rugolotto, S., Chiaffoni, G.P., Padovani, E.M., Franchini, M. and Guidi, G.C. (2007) Routine Coagulation Tests in Newborn and Young Infants. Journal of Thrombosis and Thrombolysis, 24, 153-155.

[10]   Hoyos López, M.C., Pascual Pérez, J.M., Blanco Quirós, A., Guerola Delgado, D., Valbuena Crespo, C. and álvarez Guisasola, G. (1999) Anticoagulante lúpico en pediatria. Presentación de 4 casos. Anales Espanoles de Pediatria, 51, 637-642.

[11]   Marioni, G. and de Filippi, C. (2009) Pediatric Otolaryngologic Manifestations of Bleeding Disorders. International Journal of Pediatric Otorhinolaryngology, 735, S61-S64.

[12]   Chng, W.J., Sum, C. and Kuperan, P. (2005) Causes of Isolated Prolonged Activated Partial Thromboplastin Time in an Acute Care General Hospital. Singapore Medical Journal, 46, 450-246.

[13]   Gabriel, P., Mazoit, X. and Ecoffey, C. (2000) Relationship between Clinical History, Coagulation Tests, and Perioperative Bleeding during Tonsillectomies in Pediatrics. Journal of Clinical Anesthesia, 12, 288-291.

[14]   Sandoval, C., Garcia, C., Visintainer, P., Ozkaynak, M.F. and Jayabose, S. (2003) The Usefulness of Preoperative Screening for Bleeding Disorders. Clinical Pediatrics, 42, 247-250.

[15]   Asaf, T., Reuveni, H., Yermiahu, T., Leiberman, A., Gurman, G., Porat, A., Schlaeffer, P., Shifra, S. and Kapelushnik, J. (2001) The Need for Routine Pre-Operative Coagulation Screening Tests (Prothrombin Time PT/Partial Thromboplastin Time PTT) for Healthy Children Undergoing Elective Tonsillectomy and/or Adenoidectomy International. International Journal of Pediatric Otorhinolaryngology, 61, 217-222.

[16]   Rodeghiero, F., Castaman, G., Tosetto, A., Batlle, J., Baudo, F., Cappelletti, A., Casana, P., de Bosch, N., Eikenboom, J.C., Federici, A.B., Lethagen, S., Linari, S. and Srivastava, A. (2005) The Discriminant Power of Bleeding History for the Diagnosis of von Willebrand Disease Type 1: An Interntional, Multicenter Study. Journal of Thrombosis and Haemostasis, 3, 2619-2626.

[17]   Windfuhr, J.P. and Chen, Y.S. (2002) Incidence of Post-Tonsillectomy Hemorrhage in Children and Adults: A Study of 4848 Patients. Ear, Nose & Throat Journal, 81, 626-628.

[18]   Zagólski, O. (2010) Hemorragia postamigdalectomía: tienen las pruebas de coagulación y el historial de coagulopatía un valor predictivo? Acta Otorrinolaringológica Espanola, 61, 287-292.

[19]   Koshkareva, Y.A., Cohen, M., Gaughan, J.P., Callanan, V. and Szeremeta, W. (2012) Utility of Preoperative Hematologic Screening for Pediatric Adenotonsillectomy. Ear, Nose Throat Journal, 91, 346-356.

[20]   Li, J., Lai, X., Yan, C., Xu, A., Nie, L., Zhou, Y., Liao, C. and Ren, H. (2009) Age-Associated Developmental Changes in the Activated Partial Thromboplastin Time (aPTT) and Causes of Prolonged aPTT Values in Healthy Chinese Children. Clinical Chemistry and Laboratory Medicine, 47, 1531-1537.

[21]   Burk, C.D., Miller, L., Handler, S.D. and Cohen, A.R. (1992) Preoperative History and Coagulation Screening in Children Undergoing Tonsillectomy. Pediatrics, 89, 691-695.

[22]   Genecov, D.G., Por, Y.C., Barcelo, C.R., Salyer, K.E., Mulne, A.F. and Morad, A.B. (2005) Preoperative Screening for Coagulopathy Using Prothrombin Time and Partial Thromboplastin Time in Patients Requiring Primary Cranial Vault. Plastic and Reconstructive Surgery, 116, 389-394.